LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Momelotinib | 0.37 | uM | LJP5 | 2 | P10 | 72 | hr | 929 | 2543 | 3228 | 0.7878 | 0.7020 |
Hs 578T | Momelotinib | 0.37 | uM | LJP5 | 3 | P10 | 72 | hr | 929 | 2523 | 3228 | 0.7816 | 0.6933 |
Hs 578T | Dasatinib | 0.37 | uM | LJP5 | 1 | D04 | 72 | hr | 929 | 1299 | 3228 | 0.4024 | 0.1609 |
Hs 578T | Dasatinib | 0.37 | uM | LJP5 | 2 | D04 | 72 | hr | 929 | 1266 | 3228 | 0.3922 | 0.1465 |
Hs 578T | Dasatinib | 0.37 | uM | LJP5 | 3 | D04 | 72 | hr | 929 | 1486 | 3228 | 0.4603 | 0.2422 |
Hs 578T | Dasatinib | 0.37 | uM | LJP6 | 1 | I04 | 72 | hr | 929 | 1150 | 3228 | 0.3563 | 0.0960 |
Hs 578T | Dasatinib | 0.37 | uM | LJP6 | 2 | I04 | 72 | hr | 929 | 1248 | 3228 | 0.3866 | 0.1387 |
Hs 578T | Dasatinib | 0.37 | uM | LJP6 | 3 | I04 | 72 | hr | 929 | 1125 | 3228 | 0.3485 | 0.0852 |
Hs 578T | Dovitinib | 0.37 | uM | LJP5 | 1 | E22 | 72 | hr | 929 | 1662 | 3228 | 0.5149 | 0.3188 |
Hs 578T | Dovitinib | 0.37 | uM | LJP5 | 2 | E22 | 72 | hr | 929 | 1731 | 3228 | 0.5362 | 0.3488 |
Hs 578T | Dovitinib | 0.37 | uM | LJP5 | 3 | E22 | 72 | hr | 929 | 1629 | 3228 | 0.5046 | 0.3044 |
Hs 578T | Enzastaurin | 0.37 | uM | LJP5 | 1 | D16 | 72 | hr | 929 | 3315 | 3228 | 1.0269 | 1.0378 |
Hs 578T | Enzastaurin | 0.37 | uM | LJP5 | 2 | D16 | 72 | hr | 929 | 3252 | 3228 | 1.0074 | 1.0104 |
Hs 578T | Enzastaurin | 0.37 | uM | LJP5 | 3 | D16 | 72 | hr | 929 | 3242 | 3228 | 1.0043 | 1.0061 |
Hs 578T | Erlotinib | 0.37 | uM | LJP5 | 1 | M22 | 72 | hr | 929 | 3049 | 3228 | 0.9445 | 0.9221 |
Hs 578T | Erlotinib | 0.37 | uM | LJP5 | 2 | M22 | 72 | hr | 929 | 3146 | 3228 | 0.9746 | 0.9643 |
Hs 578T | Erlotinib | 0.37 | uM | LJP5 | 3 | M22 | 72 | hr | 929 | 3019 | 3228 | 0.9352 | 0.9091 |
Hs 578T | Foretinib | 0.37 | uM | LJP5 | 1 | H10 | 72 | hr | 929 | 1974 | 3228 | 0.6115 | 0.4545 |
Hs 578T | Foretinib | 0.37 | uM | LJP5 | 2 | H10 | 72 | hr | 929 | 2122 | 3228 | 0.6574 | 0.5189 |
Hs 578T | Foretinib | 0.37 | uM | LJP5 | 3 | H10 | 72 | hr | 929 | 2067 | 3228 | 0.6403 | 0.4949 |
Hs 578T | R406 | 0.37 | uM | LJP6 | 1 | C16 | 72 | hr | 929 | 2727 | 3228 | 0.8448 | 0.7820 |
Hs 578T | R406 | 0.37 | uM | LJP6 | 2 | C16 | 72 | hr | 929 | 2748 | 3228 | 0.8513 | 0.7912 |
Hs 578T | R406 | 0.37 | uM | LJP6 | 3 | C16 | 72 | hr | 929 | 2869 | 3228 | 0.8888 | 0.8438 |
Hs 578T | Pictilisib | 0.37 | uM | LJP6 | 1 | D22 | 72 | hr | 929 | 1971 | 3228 | 0.6106 | 0.4532 |
Hs 578T | Pictilisib | 0.37 | uM | LJP6 | 2 | D22 | 72 | hr | 929 | 1870 | 3228 | 0.5793 | 0.4092 |